Filings

7 documents · 24 matches

1. APRE Aprea Therapeutics, Inc. 10-Q 2026-05-13

   Item 1A. Risk Factors

   tariffs were imposed on all countries and individualized “reciprocal” higher tariffs on certain countries with which the United States has the largest
   4 matches in this document Show context Copy citation

2. APRE Aprea Therapeutics, Inc. 10-Q 2025-11-12

   Item 1A. Risk Factors

   tariffs were imposed on all countries and individualized “reciprocal” higher tariffs on certain countries with which the United States has the largest
   4 matches in this document Show context Copy citation

3. APRE Aprea Therapeutics, Inc. 10-Q 2025-08-12

   Item 1A. Risk Factors

   tariffs were imposed on all countries and individualized “reciprocal” higher tariffs on certain countries with which the United States has the largest
   4 matches in this document Show context Copy citation

4. APRE Aprea Therapeutics, Inc. 10-K 2026-03-16

   Item 1A. Risk Factors

   tariffs were imposed on all countries and individualized “reciprocal” higher tariffs on certain countries with which the United States has the largest
   4 matches in this document Show context Copy citation

5. APRE Aprea Therapeutics, Inc. 10-Q 2026-11-04

   Item 1A. Risk Factors

   tariffs on imports from multiple countries, created uncertainty in global supply chains that could affect our ability to source clinical
   4 matches in this document Show context Copy citation

6. APRE Aprea Therapeutics, Inc. 10-Q 2026-08-12

   Item 1A. Risk Factors

   tariffs on imports from multiple countries, created uncertainty in global supply chains that could affect our ability to source clinical
   3 matches in this document Show context Copy citation

7. APRE Aprea Therapeutics, Inc. 10-Q 2025-05-14

   Item 1A. Risk Factors

   tariffs, taxes and other limitations on cross-border operations that impact U.S.-China relations and escalate tensions between China and Taiwan
   1 match in this document Show context Copy citation